by Derek Monson | Sep 30, 2020
Prescription Drugs 101: Executive order on international reference pricing Written by This is part 5 of an ongoing series seeking to describe and decode the prescription drug market for policymakers and the public so we can understand the price we pay at the...
by Sutherland Institute | Sep 23, 2020
Sutherland signs open letter on healthcare reform Written by Sutherland Institute Today Sutherland Institute announced its participation as a signatory of an open letter to the American people from 68 leaders of the Health Policy Consensus Group. From the...
by Derek Monson | Sep 15, 2020
Prescription Drugs 101: One visual to rule them all Written by The prescription drug market can seem like a complex web. It has multiple players and money is constantly moving. This visual describes where and how the money flows as prescription drugs travel...
by Derek Monson | Sep 15, 2020
Prescription Drugs 101: The 6 things that determine the price we pay Written by This is part 4 of an ongoing series seeking to describe and decode the prescription drug market for policymakers and the public so we can understand the price we pay at the...
by Derek Monson | Sep 4, 2020
Prescription Drugs 101: Follow the money Written by This is part 3 of an ongoing series seeking to describe and decode the prescription drug market for policymakers and the public so we can understand the price we pay at the pharmacy. In previous parts, we...
by Derek Monson | Aug 27, 2020
Prescription Drugs 101: The players Written by This is part 1 of an ongoing series seeking to describe and decode the prescription drug market for policymakers and interested members of the public, to understand the price we pay at the pharmacy. In this part,...